Stem Cells in Ophthalmology and Vision Restoration
Stem cell research has opened new possibilities for treating vision-related disorders and restoring damaged ocular tissues. This area focuses on the application of stem cell technologies in eye regeneration and ophthalmic therapies. Researchers will discuss advances in retinal regeneration, corneal repair, and stem cell-based treatments for visual impairment. The topic highlights recent developments in using pluripotent and adult stem cells for restoring eye function. Experts will explore challenges related to cell integration, immune response, and long-term safety of ocular therapies. Discussions will include emerging clinical trials and innovative approaches in regenerative ophthalmology. This area provides opportunities for collaboration between ophthalmologists, researchers, and regenerative medicine specialists.
- Retinal stem cell therapies
- Corneal regeneration approaches
- Stem cell applications in eye diseases
Related Conference of Stem Cells in Ophthalmology and Vision Restoration
19th International Conference on Human Genomics and Genomic Medicine
22nd World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
17th International Conference on Human Genetics and Genetic Diseases
Stem Cells in Ophthalmology and Vision Restoration Conference Speakers
Recommended Sessions
- Adult Stem Cells and Tissue-Specific Stem Cells
- Artificial Intelligence, Bioinformatics, and Stem Cell Research
- Cancer Stem Cells and Oncology Applications
- Embryonic Stem Cells and Induced Pluripotent Stem Cells
- Future Perspectives and Innovations in Stem Cell Research
- Gene Editing and Stem Cell Engineering
- Organoids, 3D Cell Culture, and Advanced Stem Cell Models
- Regenerative Medicine and Tissue Engineering
- Stem Cell Applications in Diabetes and Metabolic Disorders
- Stem Cell Applications in Immunology and Immune Therapies
- Stem Cell Applications in Wound Healing and Skin Regeneration
- Stem Cell Biology and Fundamental Research
- Stem Cell Ethics, Regulations, and Clinical Translation
- Stem Cell Manufacturing and Bioprocessing Technologies
- Stem Cell-Based Drug Discovery and Disease Modeling
- Stem Cell-Based Therapies and Clinical Applications
- Stem Cells in Cardiovascular Regeneration
- Stem Cells in Neurological Disorders and Brain Repair
- Stem Cells in Ophthalmology and Vision Restoration
- Stem Cells in Orthopedics and Musculoskeletal Regeneration
Related Journals
Are you interested in
- Achieving efficient delivery and editing - CRISPR 2026 (UAE)
- Advanced Imaging and Single-Cell Technologies - cellscience-cs-2027 (UK)
- Animal Genetics - Genome 2027 (Germany)
- Artificial Intelligence in Cell and Molecular Research - cellscience-cs-2027 (UK)
- Bioinformatics and Computational Biology - cellscience-cs-2027 (UK)
- Bioinformatics and Computational Biology - Genome 2027 (Germany)
- Biomarkers and Microarrays - Genome 2027 (Germany)
- Biotechnology and Molecular Therapeutics - cellscience-cs-2027 (UK)
- Cancer and stem cells - CRISPR 2026 (UAE)
- Cancer Cell Biology and Molecular Oncology - cellscience-cs-2027 (UK)
- Cancer Genomics - Genome 2027 (Germany)
- Cell Biology and Cellular Mechanisms - cellscience-cs-2027 (UK)
- Cellular Metabolism and Metabolic Biology - cellscience-cs-2027 (UK)
- Cellular signaling and Signal Transduction - cellscience-cs-2027 (UK)
- Clinical genomics - Genome 2027 (Germany)
- Comparative Genomics - Genome 2027 (Germany)
- CRISPR technologies and society - CRISPR 2026 (UAE)
- CRISPR technologies beyond genome editing and gene regulation - CRISPR 2026 (UAE)
- Emerging Technologies and Future Directions in Cell Science - cellscience-cs-2027 (UK)
- Epigenomics and Epigenetics - Genome 2027 (Germany)
- Functional Genomics - Genome 2027 (Germany)
- Gene Editing and Genetic Engineering - Genome 2027 (Germany)
- Genetic Disorder - Genome 2027 (Germany)
- Genetics, Genomics and Genome Biology - cellscience-cs-2027 (UK)
- Genome editing and gene regulation in human health - CRISPR 2026 (UAE)
- Genome editing and gene regulation in industrial bacterial biotechnology - CRISPR 2026 (UAE)
- Genome editing and gene regulation in industrial eukaryotic biotechnology - CRISPR 2026 (UAE)
- Genome Editing Methods and Novel Tools - CRISPR 2026 (UAE)
- Genomic Instability - Genome 2027 (Germany)
- Genomic Medicine - Genome 2027 (Germany)
- Horizons of CRISPR biology - CRISPR 2026 (UAE)
- Immunology and Cellular Immunity - cellscience-cs-2027 (UK)
- Microbial Genomics - Genome 2027 (Germany)
- Molecular Biology and Gene Regulation - cellscience-cs-2027 (UK)
- Molecular Diagnostics and Biomarkers - cellscience-cs-2027 (UK)
- Molecular Medicine and Translational Research - cellscience-cs-2027 (UK)
- Molecular Microbiology and Host–Pathogen Interactions - cellscience-cs-2027 (UK)
- Next generation sequencing - Genome 2027 (Germany)
- Nutrigenomics - Genome 2027 (Germany)
- Personalized and Regenerative Medicine - Genome 2027 (Germany)
- Pharmacogenomics - Genome 2027 (Germany)
- Plant and Animal Biotechnology - CRISPR 2026 (UAE)
- Plant Genomics and Molecular Pharming - Genome 2027 (Germany)
- Stem Cell Biology and Regenerative Medicine - cellscience-cs-2027 (UK)
- Structural Biology and Bioinformatics - CRISPR 2026 (UAE)
- Structural Genomics - Genome 2027 (Germany)
- Therapeutic Genome Editing - CRISPR 2026 (UAE)
- Trends in Genomics and Pharmacogenomics - Genome 2027 (Germany)
